<DOC>
	<DOCNO>NCT01726257</DOCNO>
	<brief_summary>The objective study assess safety effectiveness Endologix Nellix® System endovascular repair infrarenal abdominal aortic aneurysm ( AAA ) .</brief_summary>
	<brief_title>Safety Effectiveness Study Endovascular Abdominal Aortic Aneurysm Repair Using Nellix® System</brief_title>
	<detailed_description>This study evaluate safety effectiveness Nellix System among wide range physician consecutively enrol subject assess outcomes generalizability . Following appropriate government ethic committee/IRB approval Nellix® EndoVascular Sealing System implant eligible patient adequately inform consent join study . Enrolled patient undergo high resolution , contrast-enhanced compute tomography angiography ( CT ) scan relevant aortic aortoiliac vasculature within three month schedule procedure specify follow-up interval post-implantation . Follow-up visit occur 30 day , 6 month , annually 5 year assess aneurysm morphology , status implant device , relevant laboratory test result .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>Male female least 18 year old ; Informed consent understood sign ; Patient agree followup visit ; Have AAA sac diameter ≥5.0cm , ≥4.5 cm increase &gt; 1.0cm past year . Anatomic eligibility Nellix System per instruction use : Adequate iliac/femoral access compatible require delivery system ( diameter ≥6 mm ) ; Aneurysm blood lumen diameter ≤60mm ; Most caudal renal artery aortoiliac bifurcation length ≥100mm ; Proximal nonaneurysmal aortic neck : length ≥10mm ; lumen diameter 18 32mm ; angle ≤60° aneurysm sac ; Common iliac artery lumen diameter 9 35mm blood lumen diameter ≤35mm ; Ability preserve least one hypogastric artery . Life expectancy &lt; 2 year ; Psychiatric condition may interfere study ; Participating enrollment another clinical study Known allergy device device component ; Coagulopathy uncontrolled bleed disorder ; Ruptured , leak mycotic aneurysm ; Serum creatinine level &gt; 2.0mg/dL ; CVA MI within three month enrollment/treatment ; Aneurysmal disease descend thoracic aorta ; Clinically significant infrarenal mural thrombus ( &gt; 5mm thickness &gt; 50 % circumference ) ; Connective tissue disease ( e.g. , Marfan Syndrome ) Unsuitable vascular anatomy ; Pregnant ( female childbearing potential ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Infrarenal</keyword>
	<keyword>Abdominal</keyword>
	<keyword>Aortic</keyword>
	<keyword>Aneurysm</keyword>
	<keyword>AAA</keyword>
	<keyword>Endologix</keyword>
	<keyword>EVAS</keyword>
	<keyword>EndoVascular</keyword>
	<keyword>Sealing</keyword>
	<keyword>System</keyword>
</DOC>